Accepted at 1:01 a.m. Nov, 01, 2023 by dollajas
Author: shmuelsash
Related Note: 1509215808558
Rationale for change

Make a card abt the info in extra?
It would help answer this question in amboss
https://next.amboss.com/us/shared/questions/6il8js95W/5

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize



Physeo
Empty field
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::03_Cytotoxic_Nucleoside_Analogs #AK_Step1_v12::#UWorld::Step::15293 !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#UWorld::COMLEX::26221 #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::01_Antimetabolites #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::12_Antimetabolites::Nucleoside_Analogs::Cladribine #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::12_Antimetabolites #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#AMBOSS::PkaWLk